Insider · CIK 0001780649
Chad M Robins
ceochairofficerdirector
Files at ADPT (Adaptive Biotechnologies Corp). First filing Feb 18, 2025, latest Dec 1, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $12M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ADPT: Adaptive Biotechnologies Corp
ADPTOct 9, 2026 · close 26.49
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Adaptive Biotechnologies Corp | $3.1M 160,734 shares | -6% | +247% from low-4% from high | |
| 45Moderate | Adaptive Biotechnologies Corp | $1.3M 89,265 shares | -3% | +237% from low-18% from high | |
| 65Notable | Adaptive Biotechnologies Corp | $1.6M 219,569 shares | -7% | +101% from low-6% from high | |
| 35Weak | Adaptive Biotechnologies Corp | $2.4M 285,187 shares | -10% | +109% from low-2% from high | |
| 20Weak | Adaptive Biotechnologies Corp | $4.0M 470,368 shares | -18% | +113% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -35,736 | $19.68 | $703k | 2,834,239 | Dec 1, 2025 |
| Dec 1, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -124,998 | $18.94 | $2.4M | 2,709,241 | Dec 1, 2025 |
| Nov 10, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -86,161 | $14.73 | $1.3M | 2,873,088 | Nov 12, 2025 |
| Nov 11, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -1,237 | $14.57 | $18k | 2,871,851 | Nov 12, 2025 |
| Nov 12, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -1,867 | $15.00 | $28k | 2,869,975 | Nov 12, 2025 |
| Mar 4, 2025 | ADPT Adaptive Biotechnologies Corp | AGrant or award Common Stock | +355,000 | $0.00 | $0 | 2,931,701 | Mar 6, 2025 |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock | -81,206 | $6.98 | $567k | 2,850,495 | Mar 6, 2025 |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock | -36,145 | $6.99 | $253k | 2,814,350 | Mar 6, 2025 |
| Mar 5, 2025 | ADPT Adaptive Biotechnologies Corp | AGrant or award Common Stock | +247,117 | $0.00 | $0 | 3,061,467 | Mar 6, 2025 |
| Mar 6, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock | -102,218 | $7.64 | $781k | 2,959,249 | Mar 6, 2025 |
| Feb 19, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +186,080 | $6.32 | $1.2M | 2,762,781 | Feb 21, 2025 |
| Feb 19, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -186,080 | $8.46 | $1.6M | 2,576,701 | Feb 21, 2025 |
| Feb 20, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +99,107 | $6.32 | $626k | 2,675,808 | Feb 21, 2025 |
| Feb 20, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -99,107 | $8.44 | $836k | 2,576,701 | Feb 21, 2025 |
| Feb 19, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -186,080 | $0.00 | $0 | 99,107 | Feb 21, 2025 |
| Feb 20, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -99,107 | $0.00 | $0 | 0 | Feb 21, 2025 |
| Feb 13, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +100,287 | $6.32 | $634k | 2,676,988 | Feb 18, 2025 |
| Feb 13, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -100,287 | $8.44 | $846k | 2,576,701 | Feb 18, 2025 |
| Feb 14, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +158,921 | $6.32 | $1.0M | 2,735,622 | Feb 18, 2025 |
| Feb 14, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -158,921 | $8.46 | $1.3M | 2,576,701 | Feb 18, 2025 |
| Feb 18, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Common Stock10b5-1 | +211,160 | $6.32 | $1.3M | 2,787,861 | Feb 18, 2025 |
| Feb 18, 2025 | ADPT Adaptive Biotechnologies Corp | SOpen-market sale Common Stock10b5-1 | -211,160 | $8.50 | $1.8M | 2,576,701 | Feb 18, 2025 |
| Feb 13, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -100,287 | $0.00 | $0 | 655,268 | Feb 18, 2025 |
| Feb 14, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -158,921 | $0.00 | $0 | 496,347 | Feb 18, 2025 |
| Feb 18, 2025 | ADPT Adaptive Biotechnologies Corp | MOption exercise Stock Option (right to buy)derivative10b5-1 | -211,160 | $0.00 | $0 | 285,187 | Feb 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.